Gouws Capital LLC’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$567K Hold
840
– – 0.27% 36
2026
Q2
$421K Hold
840
– – 0.2% 40
2026
Q1
$413K Hold
840
– – 0.22% 41
2025
Q4
$487K Sell
840
-70
-8% -$39.6K 0.26% 36
2025
Q3
$441K Sell
910
-30
-3% -$14K 0.24% 39
2025
Q2
$381K Hold
940
– – 0.21% 42
2025
Q1
$468K Buy
940
+440
+88% +$238K 0.28% 36
2024
Q4
$260K Hold
500
– – 0.18% 40
2024
Q3
$309K Hold
500
– – 0.21% 39
2024
Q2
$277K Hold
500
– – 0.2% 39
2024
Q1
$291K Hold
500
– – 0.22% 39
2023
Q4
$265K Hold
500
– – 0.22% 40
2023
Q3
$253K Sell
500
-300
-38% -$160K 0.21% 43
2023
Q2
$417K Hold
800
– – 0.34% 37
2023
Q1
$461K Sell
800
-100
-11% -$56.4K 0.41% 34
2022
Q4
$496K Hold
900
– – 0.47% 33
2022
Q3
$456K Hold
900
– – 0.45% 34
2022
Q2
$489K Hold
900
– – 0.46% 35
2022
Q1
$532K Hold
900
– – 0.43% 36
2021
Q4
$601K Buy
+900
New +$562K 0.49% 33

Other funds holding TMO

Gouws Capital LLC's TMO Position: Q3 2026 in Review

Gouws Capital LLC held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 840 shares worth $567K. The position accounts for 0.27% of the portfolio, ranked #36.

Gouws Capital LLC first reported a position in TMO in Q4 2021 and has held it in 20 quarters since. The position peaked at $601K in Q4 2021. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Gouws Capital LLC held 840 shares of Thermo Fisher Scientific worth $567K as of Q3 2026.
  • Gouws Capital LLC left its Thermo Fisher Scientific share count unchanged in Q3 2026.
  • Thermo Fisher Scientific made up 0.27% of Gouws Capital LLC's portfolio in Q3 2026, its #36 holding.
  • Gouws Capital LLC first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 20 quarters since.
  • Gouws Capital LLC's Thermo Fisher Scientific position peaked at $601K in Q4 2021.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Gouws Capital LLC's 13F filing for Q3 2026, filed 9 Oct 2026.